EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Total Assets Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual total assets in 2023 was 172.04 Billion KRW , up 9.02% from previous year.
EASY BIO,Inc.'s latest quarterly total assets in 2024 Q1 was 255.4 Billion KRW , up 48.46% from previous quarter.
EASY BIO,Inc. reported annual total assets of 157.81 Billion KRW in 2022, up 34.09% from previous year.
EASY BIO,Inc. reported annual total assets of 117.69 Billion KRW in 2021, up 31.03% from previous year.
EASY BIO,Inc. reported quarterly total assets of 336.94 Billion KRW for 2024 Q2, up 31.93% from previous quarter.
EASY BIO,Inc. reported quarterly total assets of 154.98 Billion KRW for 2023 Q2, down -7.59% from previous quarter.

Annual Total Assets Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Total Assets of EASY BIO,Inc. (2023 - 2020)

Year	Total Assets	Total Assets Growth
2023	172.04 Billion KRW	9.02%
2022	157.81 Billion KRW	34.09%
2021	117.69 Billion KRW	31.03%
2020	89.82 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	255.4 Billion KRW	48.46%
2024 Q2	336.94 Billion KRW	31.93%
2023 Q2	154.98 Billion KRW	-7.59%
2023 FY	172.04 Billion KRW	9.02%
2023 Q4	172.04 Billion KRW	-2.84%
2023 Q3	177.06 Billion KRW	14.24%
2023 Q1	167.71 Billion KRW	6.27%
2022 Q1	123.44 Billion KRW	4.89%
2022 FY	157.81 Billion KRW	34.09%
2022 Q4	157.81 Billion KRW	-14.45%
2022 Q3	184.47 Billion KRW	19.26%
2022 Q2	154.67 Billion KRW	25.3%
2021 Q4	117.69 Billion KRW	-3.65%
2021 Q3	122.15 Billion KRW	13.63%
2021 Q2	107.5 Billion KRW	9.44%
2021 FY	117.69 Billion KRW	31.03%
2021 Q1	98.23 Billion KRW	9.37%
2020 Q3	83.68 Billion KRW	6.0%
2020 Q4	89.82 Billion KRW	7.33%
2020 Q2	78.94 Billion KRW	0.0%
2020 FY	89.82 Billion KRW	0.0%

Peer Total Assets Comparison of EASY BIO,Inc.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	77.114%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-74.459%
BINEX Co., Ltd.	257.01 Billion KRW	33.061%
Bioneer Corporation	315.48 Billion KRW	45.468%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-15.131%
MEDIPOST Co., Ltd.	449.39 Billion KRW	61.717%
CrystalGenomics, Inc.	243.11 Billion USD	29.235%
Helixmith Co., Ltd	227.27 Billion KRW	24.304%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	90.03%
Medy-Tox Inc.	611.62 Billion KRW	71.871%
Peptron, Inc.	52.49 Billion KRW	-227.723%
Amicogen, Inc.	467.09 Billion KRW	63.168%
Genexine, Inc.	376.58 Billion KRW	54.316%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	14.32%
LegoChem Biosciences, Inc.	189.5 Billion KRW	9.214%
ALTEOGEN Inc.	256.09 Billion KRW	32.823%
PharmaResearch Co., Ltd.	535.28 Billion KRW	67.86%
SillaJen, Inc.	76.71 Billion KRW	-124.261%
JETEMA, Co., Ltd.	252.14 Billion KRW	31.769%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-67.315%
Genomictree Inc.	132.84 Billion KRW	-29.506%
MedPacto, Inc.	80.47 Billion KRW	-113.784%
D&D Pharmatech	79.2 Billion KRW	-117.214%
GI Innovation, Inc.	81.34 Billion KRW	-111.509%